c-LEcta
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Perlickstr. 5, Leipzig, Saxony, 04103, G...Phone Number
+49 3413552140Website
www.c-lecta.comRevenue
$11.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About c-LEcta
c-LEcta GmbH is a global biotechnology company focused on developing, producing, and distributing enzyme products primarily for the food and pharmaceutical industries. The company utilizes advanced enzyme engineering technologies to offer innovative biotechnological solutions that enhance food production and pharmaceutical applications. With over 400 international customers, c-LEcta provides quality enzyme solutions that support the production of food ingredients and new therapeutic forms. As part of the Kerry Group, c-LEcta is committed to driving innovation and meeting high-quality standards in biotech solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is c-LEcta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once c-LEcta has new funding data
Check out if c-LEcta is spiking on competitors!
Product Launch: Get notified when c-LEcta launches new products
c-LEcta, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if c-LEcta has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if c-LEcta had a recent Job posting/layoffs
Earning: See what the market has to say on c-LEcta recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at c-LEcta
Recommended Actions
Find VP level buyers at c-LEcta
Find 2 more new buyers
Company Profile Activity
Activity Insights
c-LEcta is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
c-LEcta is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about c-LEcta.
c-LEcta Tech Stack
A closer look at the technologies used by c-LEcta
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
Event
Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Operations
Event
Research & Development, Bioengineering, Medical Research, Clinical Operations, Operations
c-LEcta News & Media
c-LEcta Reports Record Year With Significant Growth
LEIPZIG, Germany--(BUSINESS WIRE)--c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully continued its dynamic business development in fiscal year 2021. “We are very proud of our performance in recent years. Our products have provided good growth momentum, but also great resilience due to the diverse use cases and this has supported us over the last two years. To continue to drive this growth in the long term, we haveBaker McKenzie advises Kerry Group plc on the acquisition of c-LEcta
Baker McKenzie has advised Kerry Group plc (“Kerry”), the global taste and nutrition company on the acquisition of approx. 93% of c-LEcta ...c-LEcta Announces That It Has Reached Agreement to Be Acquired by Kerry Group
LEIPZIG, Germany--(BUSINESS WIRE)--c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, has announced that it has reached an agreement with Kerry Group for it to acquire a majority shareholding of the company. Kerry is a world-leading taste and nutrition partner for the food, beverage, and pharmaceutical markets. This strategically compelling combination will accelerate Kerry’s innovation capabilities in enzyme engineering, fermentation and bio-process devec-LEcta Continues Its Growth in 2021 and Sees Itself Excellently Positioned for the Future With the ENESYZ Technology Platform
LEIPZIG, Germany--(BUSINESS WIRE)--c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, continued its growth in 2021. The high expectations for the fiscal year have been fully met and were even significantly exceeded. Thus, the management expects annual revenue in the range of EUR 20 million, which equates to a doubling of last year’s result. With an expanded team, further investments in the product range and the ENESYZ technology
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding c-LEcta
Sign Up For FreeTo access detailed company insights
c-LEcta GmbH is a global biotechnology company focused on developing, producing, and distributing enzyme products primarily for the food and pharmaceutical industries. The company utilizes advanced enzyme engineering technologies to offer innovative biotechnological solutions that enhance food production and pharmaceutical applications. With over 4... Read More
